Drug intelligence / Profile preview

placebo + mFOLFOX6

Development stage
Unknown
Modality
Small Molecules
Administration
Intravenous
01

Overview

This is a combination regimen used in clinical trials as a control arm, consisting of a placebo administered alongside the chemotherapy regimen known as modified FOLFOX6 (mFOLFOX6). The mFOLFOX6 regimen includes three drugs: - Oxaliplatin (a platinum-based chemotherapeutic) - Leucovorin (folinic acid) - 5-Fluorouracil (5-FU) The "placebo" component is an inert substance given to maintain blinding in randomized controlled trials. The active chemotherapy agents work by interfering with DNA synthesis and function in rapidly dividing cells. Oxaliplatin forms DNA crosslinks; 5-fluorouracil inhibits thymidylate synthase and incorporates into RNA/DNA; leucovorin enhances the binding of 5-FU to its target enzyme. This combination is standard for colorectal cancer and sometimes other gastrointestinal cancers[1][2][4][5][6].

Other names
placebo plus modified FOLFOX6placebo + FOLFOXplacebo with oxaliplatin/leucovorin/fluorouracil
02

Targets

DNATS (Thymidylate synthase)

Beyond the preview

Go deeper on placebo + mFOLFOX6.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on placebo + mFOLFOX6.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call